# A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

> **NCT04925947** · PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 4 (actual)

## Conditions studied

- Thymic Carcinoma

## Interventions

- **DRUG:** KN046

## Key facts

- **NCT ID:** NCT04925947
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-13
- **Primary completion:** 2023-05-05
- **Final completion:** 2023-05-05
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Data collected did not support the study endpoints
- **Last updated:** 2024-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04925947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04925947, "A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04925947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*